Giancarlo Comi, MD
Treatment of Progressive MS: Why, Who, When, How
More Than “Women’s Issues": Women’s Reproductive and Gynaecological Health and Work
More Than “Women’s Issues": Women’s Reproductive and Gynaecological Health a...
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active R...
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Jiwon Oh, MD
The Diagnostic Challenges of Spinal Cord Lesions in MS
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Res...
Reducing the Burden of MS Treatment
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Multiple Sclerosis Physician Resources
Highlights from the MAGNIMS Consensus Guidelines
Immunologic Effects on Metabolic Syndrome and MS
Current Landscape of MS Diagnosis/Prognosis
Early Diagnosis/Long-Term Prognosis of MS - Dr. Jiwon Oh
Current and Future MS Treatment Options
Determining an MS Patient's Long-Term Prognosis
The Value of Biomarkers in MS Patients
Stay current with the best on medical education
We’re glad to see you’re enjoying Global Neurology Academy…but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.